Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:1115-1122
Published online before print September 8, 2009, doi: 10.1161/CIRCULATIONAHA.109.849208
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/12/1115    most recent
CIRCULATIONAHA.109.849208v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de Assis, M. C.
Right arrow Articles by Rohde, L. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Assis, M. C.
Right arrow Articles by Rohde, L. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Thinners
Related Collections
Right arrow Coagulation
Right arrow Coumarins
Right arrowRelated Article

(Circulation. 2009;120:1115-1122.)
© 2009 American Heart Association, Inc.


Vascular Medicine

Improved Oral Anticoagulation After a Dietary Vitamin K–Guided Strategy

A Randomized Controlled Trial

Michelli C. de Assis, RN; Eneida R. Rabelo, RN, ScD; Christiane W. Ávila, RN; Carisi Anne Polanczyk, MD, ScD; Luis E. Rohde, MD, ScD

From the Cardiovascular Division of Hospital de Clínicas de Porto Alegre, Postgraduation Program in Cardiology and Cardiovascular Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Correspondence to Luis E. Rohde, MD, ScD, Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Sala 2061, Porto Alegre, RS, Brazil 90035-003. E-mail lerohde{at}terra.com.br

Received January 12, 2009; accepted July 2, 2009.

Background— Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies.

Methods and Results— In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K–guided strategy based on simple modifications of the amount of vitamin K–rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n=132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K–guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P=0.04). Patients allocated to the dietary vitamin K–guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P=0.06).

Conclusions— A vitamin K–guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 1021-1023. [Extract] [Full Text]